Meeting on the Mesa 2026 has ended. This guide stays up as the record of who was there. Next: Meeting on the Mesa 2027, Oct 18–20, 2027 in Phoenix

Rare disease at Meeting on the Mesa 2026

Oct 5–7, 2026 Phoenix, AZ ~1.5k attendees Website

72 organizations at Meeting on the Mesa 2026 present work in rare disease: 56 therapy developers, 9 academic, hospital and public organizations, 6 suppliers and service providers and 1 investor. Between them they bring 50 presentations to the program. Most represented: Arbor Biotechnologies, Children’s National Hospital and CTI Clinical Trial & Consulting Services. As of Oct 6, 2026.

All 592 organizations at Meeting on the Mesa 2026 →

Format
Top represented
Showing 1–15 of 72 organizations
OrganizationMeeting on the Mesa 2026 Attendance
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops gene-editing therapeutics for genetic diseases, including liver and central nervous system conditions and rare disorders.
◇Silver Sponsor
Hospital & health systemSilver Sponsor
Provides pediatric hospital care and develops treatments for genetic and rare diseases through clinical and translational research.
Spotlight
Mon, Oct 5
5:15pm
Innovation Spotlight company presentation
Panel
Mon, Oct 5
10:45am
Delivering CAR-T: Expanding Access to Transform Patient Care
◆Diamond Sponsor
Services & consultingDiamond Sponsor
Provides clinical research, regulatory consulting, site management, and laboratory services for biopharmaceutical trials, including cell and gene therapies and rare diseases.
Spotlight
Mon, Oct 5
3:00pm
Chair
Mon, Oct 5
1:30pm
Attendee
Attendee
◆Platinum Sponsor
Services & consultingPlatinum Sponsor
Provides biomarker-driven CRO services, clinical trials, specialty laboratories, biospecimens, data science, and companion diagnostic support.
Spotlight
Mon, Oct 5
12:00pm
Attendee
Attendee
REGENXBIO
Rockville, MD
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops AAV gene therapies for retinal and rare diseases, including programs for wet AMD, diabetic retinopathy, Duchenne muscular dystrophy, and MPS II.
Spotlight
Mon, Oct 5
11:00am
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops gene therapies for rare cardiovascular diseases, with additional programs in hematology and immunology and proprietary AAV manufacturing capabilities.
uniQure
Amsterdam, Netherlands
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops one-time gene therapies for hemophilia, Huntington’s disease, epilepsy, Fabry disease, and other severe conditions.
Spotlight
Mon, Oct 5
3:15pm
Innovation Spotlight company presentation
Ocugen
Malvern, PA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops gene and cell therapies for inherited retinal diseases, blindness and other serious conditions.
Panel
Tue, Oct 6
2:15pm
Leadership Perspectives: Beyond the Breakthrough
◇Silver Sponsor
Pharma & large biotechSilver Sponsor
Develops and commercializes therapies for cancer, transplant-related disease, and rare genetic disorders.
Panel
Tue, Oct 6
2:15pm
RARE Foundation
Washington, DC
◇Silver Sponsor
Patient advocacy & nonprofitSilver Sponsor
Advocates for rare-disease patients through policy research, regulatory engagement, community programs, and access initiatives.
BridgeBio
Palo Alto, CA
◇Silver Sponsor
Pharma & large biotechSilver Sponsor
Develops medicines for genetic conditions through autonomous teams focused on underserved and rare diseases.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
◆Gold Sponsor
Services & consultingGold Sponsor
Provides clinical development, trial management, regulatory, and market-access services, with expertise in rare diseases and complex therapies.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Attendee
○Event Supporter
Patient advocacy & nonprofitEvent Supporter
Supports children and families affected by rare diseases through Canadian patient advocacy, research connections, and care resources.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Solid Biosciences
Charlestown, MA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops genetic medicines for Duchenne muscular dystrophy and other serious diseases, including gene therapies and genetic medicines for cardiac conditions.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Patient advocacy & nonprofit
Patient advocacy nonprofit advancing therapies for Angelman syndrome and other rare monogenic neurodevelopmental disorders through venture philanthropy.
Spotlight
Mon, Oct 5
9:45am

Explore the full Meeting on the Mesa 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full Meeting on the Mesa 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in rare disease

Tell us what you sell and we’ll find the people at organizations working on rare disease most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse Meeting on the Mesa 2026 by

Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction